The University of Oklahoma
The University of Oklahoma
Oklahoma City, Oklahoma, United States2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Nutritional and Metabolic Diseases, hematologic disorder, hereditary disease, inherited hemoglobinopathy, metabolic disease | Recruiting | Phase 1 / Phase 2 | 2026-09-16 | NCT00920972 | |
| The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms | Aneurysm, Bites and Stings, Chemically-Induced Disorders, Fusiform Aneurysm, Saccular Aneurysm, brain aneurysm, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hemorrhagic stroke, injury, intracranial arterial disease, nervous system disorder, poisoning, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-09-09 | NCT07143019 |